Bank of Montreal Can Acquires 1,740 Shares of Sotera Health (NASDAQ:SHC)

Bank of Montreal Can increased its stake in Sotera Health (NASDAQ:SHC) by 10.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 18,184 shares of the company’s stock after purchasing an additional 1,740 shares during the quarter. Bank of Montreal Can’s holdings in Sotera Health were worth $249,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Blue Trust Inc. lifted its holdings in shares of Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after purchasing an additional 1,140 shares in the last quarter. GAMMA Investing LLC lifted its stake in shares of Sotera Health by 37.5% in the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock valued at $56,000 after buying an additional 1,121 shares in the last quarter. PNC Financial Services Group Inc. grew its holdings in shares of Sotera Health by 39.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company’s stock valued at $127,000 after buying an additional 2,627 shares during the last quarter. Rangeley Capital LLC bought a new stake in shares of Sotera Health during the fourth quarter worth about $192,000. Finally, Envestnet Portfolio Solutions Inc. increased its position in shares of Sotera Health by 17.3% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company’s stock worth $217,000 after acquiring an additional 2,340 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on SHC. Piper Sandler cut their price target on Sotera Health from $15.00 to $13.00 and set a “neutral” rating for the company in a research note on Wednesday. Barclays cut their target price on Sotera Health from $16.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, April 10th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Sotera Health currently has a consensus rating of “Moderate Buy” and an average target price of $15.20.

Sotera Health Stock Performance

SHC stock opened at $11.30 on Friday. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The firm has a market cap of $3.21 billion, a PE ratio of 45.20 and a beta of 1.88. The business has a 50 day moving average of $11.61 and a 200-day moving average of $13.20. Sotera Health has a 12-month low of $9.53 and a 12-month high of $17.08.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.